WKEY vs. RXRX

Last updated Aug 1, 2026

WKEY (WISeKey International Holding AG) and RXRX (Recursion Pharmaceuticals, Inc.) are both stocks. WKEY operates in Semiconductors (Technology), while RXRX operates in Biotechnology (Healthcare). Over the past 5 years, WKEY returned -29.07%/yr vs -37.05%/yr for RXRX. Their 0.26 correlation means their historical movements had little consistent relationship.

Performance

WKEY vs. RXRX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in WISeKey International Holding AG (WKEY) and Recursion Pharmaceuticals, Inc. (RXRX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, WKEY achieves a -21.78% return, which is significantly higher than RXRX's -26.65% return.

WKEY

• 1D: -4.21%
• 1M: -11.84%
• 6M: -17.80%
• YTD: -21.78%
• 1Y: 16.51%
• 3Y*: 14.60%
• 5Y*: -29.07%
• 10Y*: —
• ALL TIME*: -30.53%

RXRX

• 1D: -1.32%
• 1M: -21.05%
• 6M: -28.40%
• YTD: -26.65%
• 1Y: -47.18%
• 3Y*: -39.89%
• 5Y*: -37.05%
• 10Y*: —
• ALL TIME*: -35.29%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison

Position	Avg. Volume Value (2W)	Avg. Volume Value (1M)	Avg. Volume Value (3M)
RXRX Recursion Pharmaceuticals, Inc.	$52.74M	$74.51M	$69.08M
WKEY WISeKey International Holding AG	$285.27K	$368.93K	$924.82K

WKEY vs. RXRX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
WKEY WISeKey International Holding AG	-21.78%	-13.31%	417.40%	-60.67%	-77.35%	-58.01%
RXRX Recursion Pharmaceuticals, Inc.	-26.65%	-39.50%	-31.44%	27.89%	-54.99%	-42.90%

Correlation

The correlation between WKEY and RXRX is 0.49, which is low. Their historical price movements had little consistent relationship.

	Correlation
Correlation (1Y) Focuses on recent behavior, but can change the most.	0.49
Correlation (3Y) Balances recent behavior with more history.	0.29
Correlation (5Y) Shows whether the relationship held over a longer period.	0.27
Correlation (All Time) Calculated using the full available price history since Apr 16, 2021	0.26

Over the past year, WKEY and RXRX have become more correlated (0.49) than their long-term average of 0.26, meaning their price movements have been converging.

Fundamentals

Market Cap WKEY : $38.24M RXRX : $1.57B
EPS WKEY : -$2.56 RXRX : -$1.12
PS Ratio WKEY : 2.22 RXRX : 22.67
PB Ratio WKEY : 1.50 RXRX : 1.55
Total Revenue (TTM) WKEY : $31.08M RXRX : $66.29M
Gross Profit (TTM) WKEY : $12.08M RXRX : -$22.83M
EBITDA (TTM) WKEY : -$72.38M RXRX : -$505.90M

Return for Risk

WKEY vs. RXRX — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

WKEY

WKEY Risk / Return Rank: 50
WKEY Sharpe Ratio Rank: 47
WKEY Sortino Ratio Rank: 56
WKEY Omega Ratio Rank: 53
WKEY Calmar Ratio Rank: 48
WKEY Martin Ratio Rank: 47

RXRX

RXRX Risk / Return Rank: 13
RXRX Sharpe Ratio Rank: 12
RXRX Sortino Ratio Rank: 13
RXRX Omega Ratio Rank: 16
RXRX Calmar Ratio Rank: 10
RXRX Martin Ratio Rank: 14

The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

WKEY vs. RXRX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for WISeKey International Holding AG (WKEY) and Recursion Pharmaceuticals, Inc. (RXRX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	WKEY	RXRX	Difference
Sharpe ratio: Return per unit of total volatility	0.06	-0.71	+0.77
Sortino ratio: Return per unit of downside risk	0.89	-0.96	+1.85
Omega ratio: Gain probability vs. loss probability	1.10	0.90	+0.20
Calmar ratio: Return relative to maximum drawdown	0.08	-0.85	+0.94
Martin ratio: Return relative to average drawdown	0.12	-1.25	+1.36

WKEY vs. RXRX - Sharpe Ratio Comparison

The current WKEY Sharpe Ratio is 0.06, which is higher than the RXRX Sharpe Ratio of -0.71. The chart below compares the historical Sharpe Ratios of WKEY and RXRX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

WKEY vs. RXRX - Drawdown Comparison

The maximum WKEY drawdown since its inception was -98.63%, which is greater than RXRX's maximum drawdown of -93.13%. Use the drawdown chart below to compare losses from any high point for WKEY and RXRX.

Drawdown Indicators

	WKEY	RXRX	Difference
Max Drawdown Largest peak-to-trough decline	-98.63%	-93.13%	-5.50%
Max Drawdown (1Y) Largest decline over 1 year	-69.33%	-58.17%	-11.16%
Max Drawdown (3Y) Largest decline over 3 years	-75.23%	-81.70%	+6.47%
Max Drawdown (5Y) Largest decline over 5 years	-96.78%	-90.95%	-5.83%
Current Drawdown Current decline from peak	-94.02%	-92.74%	-1.28%
Average Drawdown Average peak-to-trough decline	-76.99%	-75.79%	-1.20%
Ulcer Index Depth and duration of drawdowns from previous peaks	48.34%	39.99%	+8.35%

Volatility

WKEY vs. RXRX - Volatility Comparison

WISeKey International Holding AG (WKEY) has a higher volatility of 18.29% compared to Recursion Pharmaceuticals, Inc. (RXRX) at 17.39%. This indicates that WKEY's price experiences larger fluctuations and is considered to be riskier than RXRX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	WKEY	RXRX	Difference
Volatility (1M) Calculated over the trailing 1-month period	18.29%	17.39%	+0.90%
Volatility (6M) Calculated over the trailing 6-month period	56.38%	45.40%	+10.98%
Volatility (1Y) Calculated over the trailing 1-year period	102.23%	69.61%	+32.62%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	121.93%	93.18%	+28.75%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	120.51%	92.91%	+27.60%

Dividends

WKEY vs. RXRX - Dividend Comparison

Neither WKEY nor RXRX has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both WKEY and RXRX in my portfolio?

WKEY and RXRX have a correlation of 0.49, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, WKEY or RXRX?

WKEY has higher volatility (18.29%) compared to RXRX (17.39%). In terms of maximum drawdown, WKEY dropped -98.63% vs RXRX's -93.13%.

Which has better risk-adjusted returns?

WKEY currently has the higher Sharpe Ratio (0.06 vs -0.71), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.